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The following excerpt is from an article
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Humanities Clinical Ethics Consultation Affairs Standing Committee. HCEC
Pearls and Pitfalls: Suggested Do’s and
Don’t’s for Healthcare Ethics Consultants.
HCEC PEARLS AND PITFALLS
1. Don’t assume that the question you
are asked to address is a matter of
ethics, or that it is the primary issue
or the only issue. Do take the time to
clarify for yourself (and your team) the
following: What are the relevant concerns, and are they a matter of ethics?

The Mid-Atlantic Ethics Committee

Newsletter is a publication of the
Maryland Health Care Ethics
Committee Network, an initiative
of the University of Maryland
Francis King Carey School of Law’s
Law & Health Care Program. The
Newsletter combines educational
articles with timely information
about bioethics activities. Each issue
includes a feature article, a Calendar
of upcoming events, and a case
presentation and commentary by local
experts in bioethics, law, medicine,
nursing, or related disciplines.
Diane E. Hoffmann, JD, MS
Editor

Those requesting an ethics consultation
recognize that a problem exists. However, they may not be able to accurately
determine whether the problem is truly a
matter of ethics or not, and even if they
can, they may not be able to correctly
articulate the precise nature of the ethical
concerns (that is, the values about which
there is uncertainty or conflict). Further,
requesters may not appreciate that, in addition to the question(s) they have raised,
other important ethical concerns may be
involved. One important task for HCECs,
then, is to determine if the request is
appropriate for ethics consultation and,
if so, to clarify the ethical concern(s).1
If the request does not involve an ethics
question (that is, what should be done
in the face of uncertainty or conflict
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about values), it should be referred to
other resources in the healthcare system
that are better equipped to handle such
requests. For example, if the requester is
seeking a legal opinion, he or she should
be referred to legal counsel. Similar to
making a diagnosis in clinical medicine,
where precision in diagnosis leads to
appropriate intervention, clearly and
accurately identifying and describing the
ethical concerns in an ethics consultation will more likely lead to a correct and
helpful analysis and appropriate recommendations. Another parallel to clinical
medicine is that, as the case unfolds over
time, new issues may emerge. An initial
set of questions, even when addressed
and resolved, may lead to awareness of
new ethical issues as the case evolves.
The consultant should be attentive and
open to this possibility and revisit the
ethics question(s) in the consultation, as
needed.
2. Don’t conduct ethics consultations
a different way each time. Do have a
standardized and systematic approach
for gathering, analyzing, and synthesizing information.
“Excellence is an art won by training
and habituation: we do not act rightly
because we have virtue or excellence, but
we rather have these because we have
acted rightly; . . . we are what we repeatedly do. Excellence, then, is not an act
but a habit.”2 Excellence in ethics consulCont. on page 2

The Mid-Atlantic Ethics

Committee Newsletter
is published three times per year by
the Maryland Health Care Ethics
Committee Network
Law & Health Care Program
University of Maryland
Francis King Carey School of Law
500 West Baltimore Street
Baltimore, MD 21201
410-706-7191
Diane E. Hoffmann, JD, MS, Editor
Anita J. Tarzian, PhD, RN,
Co-Editor
Contributing Editors:
Joseph A. Carrese, MD, MPH
Associate Professor of Medicine
Johns Hopkins University
Brian H. Childs, PhD
Director, Ethics & Organizational
Development, Shore Health Systems
Evan DeRenzo, PhD
Ethics Consultant
Center for Ethics
Washington Hospital Center
Edmund G. Howe, MD, JD
Professor of Psychiatry,
U.S.U.H.S. Department of
Psychiatry
Laurie Lyckholm, MD
Asstistant Professor of Internal
Medicine and Professor of
Bioethics and Humanities,
Virginia Commonwealth
School of Medicine
Jack Schwartz, JD
Adjunct Faculty
University of Maryland
Francis King Carey School of
Law
Henry Silverman, MD, MA
Professor of Medicine
University of Maryland
Comments to:
MHECN@law.umaryland.edu
The information in this newsletter
is not intended to provide legal
advice or opinion and should not be
acted upon without consulting an
attorney.

2 Mid-Atlantic Ethics Committee Newsletter

Do's and Don't's
Cont. from page 1
tation, as in any other pursuit, is not an
accident. It is borne of commitment,
training, and the habit of approaching our work with high standards and
rigor, every single time we do a consultation. One strategy for facilitating
high quality ethics consultation is to
have a standardized process for conducting consultation that is thorough,
systematic, and employed every time.
Approaching one’s work differently
each time increases the likelihood of
omissions and mistakes. Many strategies for conducting healthcare ethics
consultations have been suggested.3
We do not endorse a particular strategy; rather, we urge HCECs and consultation services to select and use one
strategy consistently—that is, to make
it a habit, so that quality is enhanced
and excellence can be achieved.
Another advantage of a consistent
approach is that, over time, those who
request assistance from HCECs learn
what to expect.

information and when identifying,
and, in turn, evaluating, ethically
acceptable options. One strategy to
contemplate when considering this
“Pearl” is to periodically ask oneself
and others involved in the consultation the following questions: Have we
missed anything? Is there anything we
haven’t considered or anyone from
whom we haven’t heard? Have we accounted for all relevant perspectives?
Are we aware of our assumptions and
have we assessed them? Are there
other possible explanations for what
is happening? Have any new issues
emerged since we started the consultation? Have we challenged ourselves to
think creatively to identify additional
ethically supportable options?

3. Don’t come to premature closure
about the issues involved and the
options available. Do take the time
necessary to be thorough in each
step of the consultation process.

There are times when physicians
and nurses ask HCECs for advice
over the phone or in the hallway and
there can only be a brief exchange
of information and ideas. Staff may
desire a quick answer and may want to
avoid initiating a consultation process
that may take some time to complete.
Forces conspiring to truncate the ethics
consultation process can, at times, be
very significant. A concern related to
quick, curbside consultations is the
possibility of incomplete appreciation
by HCECs of all of the relevant facts
and considerations. This in turn could
lead to inappropriate or unfounded
advice. In contrast, a formal, deliberate
approach to gathering information and
discussing the issues that have been
raised enhances the likelihood that the
process and outcome will be of the
highest quality. In addition, a telephone or hallway conversation is not
captured in the medical record, and is
therefore not available for other members of the healthcare team to review

One basic rule in clinical medicine
is resisting the temptation to arrive at
a conclusion prematurely.4 Instead,
the preferred approach is to be careful, deliberate, and thorough before
arriving at a conclusion. The same
applies to healthcare ethics (HCE)
consultation. Thoroughness in all
phases of the consultation process may
take more time, but this approach is
more likely to result in sound recommendations. HCE consultants should
adhere to a systematic approach for
gathering information (such as one of
those referenced in Pearl 2) that begins
with careful chart review (for case
consultation), proceeds to interviewing stakeholders, and includes careful
reflection along the way. Similarly,
a thorough approach should be employed when analyzing the gathered

4. Don’t conduct informal “curbside” consultations when making
recommendations about a specific
patient. Do conduct formal case
consultations that are documented
in the patient’s medical record.

and reflect upon. A carefully written
formal consultation note placed in the
medical record is available to others
and serves as evidence that important
issues in the case were carefully considered by HCE experts.
However, despite the preference for
formal consultation, HCECs should be
sensitive to the needs and limitations
of those who may desire their services
but are not willing or able to engage
in a formal case consultation process.
Consultants should develop strategies for being responsive, engaged,
and helpful, even when a formal case
consultation is not being requested.5
For example, it is acceptable for
HCECs to educate and offer generic
advice to colleagues. An HCEC might
be asked by a colleague to review
and explain the key steps in assessing
decision-making capacity, as a point
of general information. Similarly, an
HCEC, before being invited to undertake a formal case consultation, might
advise careful communication between
key stakeholders (such as a meeting
between staff and family members).
The key issue here is role clarification. There is an important distinction
between providing general education
or coaching about communication
principles and giving specific advice
about a particular patient that may
lead to important decisions about that
patient’s medical care. HCECs need to
be aware of this distinction, be clear
about their role, and avoid offering
specific advice about a particular
patient unless it is in the context of a
formal case consultation.
5. Don’t allow the HCE consultation discussion to be dominated by
particular individuals. Do be facilitative, inclusive, and a good listener.
The work of an HCEC, by definition, involves interaction with multiple
parties, including patients, family
members, and staff. Clearly, either in
one’s role as a member or as a leader
of a consultation team, it is essential to
ensure that all perspectives are given
voice and that all stakeholders feel

included and respected. If one person
dominates the conversation, there is
a risk that important information will
not be communicated. Attention to
core dialogue skills such as suspension of judgment, identification of
the assumptions being made, skilled
listening and inquiry, and reflection
helps to create an inclusive, facilitative process.6 This “ethics facilitation
approach”7 decreases the likelihood
of missing crucial information and
enhances the probability of arriving at
an optimal understanding of the situation.8
6. Don’t assume your written consultation note will be understood
without verbal communication. Do
use the consultation as an opportunity to engage healthcare staff in
direct conversation to explain and
teach.
One basic premise of optimal HCE
consultation is optimal communication. Usually this means direct verbal
communication with members of the
requesting service to review key recommendations and associated reasoning, in addition to generating a written consultation note.9 Direct verbal
communication increases the likelihood that consult participants will
understand the specific ethical concerns raised during the consultation,
in part by creating an opportunity for
questions to be asked and addressed.
In this way, direct verbal communication reduces the risk of confusion or
misunderstanding. In addition, many
HCECs consider teaching and education to be part of their core mission—
that is, to help those involved learn to
work through ethical uncertainties and
disagreements on their own.10 Engaging members of the requesting service
in conversations throughout the consultation process is one way to fulfill
the HCEC’s teaching mission.
7. Don’t assume you are doing
a good job. Do invite evaluation
of your consultations from those
requesting and/or participating in
them.

A basic principle of quality improvement is to evaluate what you
are doing. One way to evaluate ethics
consultation is by getting feedback
from end users.11 While hard work and
good intentions are important, they
alone don’t ensure that HCECs are doing the best job possible. For example,
ethics consultants have blind spots
like everyone else: interactions may be
perceived by others as suboptimal in
ways that HCECs cannot appreciate.
Inviting feedback about specific aspects of the consultative process from
those who requested and participated
in the consultation is a useful way to
better understand what is going well
and what needs attention and improvement. The Department of Veterans
Affairs Integrated Ethics initiative
has many useful resources, including
an evaluation tool that can be used
to assess participants’ perceptions of
consultation performance.12 Using this
tool or a similar evaluation instrument
after every consultation, combined
with periodic review and discussion
of aggregated feedback results, is an
important step toward making necessary adjustments and providing better
ethics consultation services. Examples
of domains about which HCECs might
invite feedback include respecting the
opinions of the requestor, giving useful information, explaining effectively,
clarifying decisions to be made, clarifying appropriate decision makers,
identifying and describing ethically
supportable options, and being accessible and timely.
8. Don’t assume that everyone who
needs an ethics consultation will
know that they need one, or even
know that a consultation service exists. Do engage in outreach to raise
awareness about the existence and
role of the HCE consultation service.
Fox and colleagues found that 80
percent of U.S. hospitals and 100
percent of hospitals with 400 or more
beds have an ethics consultation
Cont. on page 4
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service.13 However, patients, family
members, and members of the hospital
community who may be involved in
patient care and who may be in a position to request an ethics consultation
may not be aware that a consultation
is needed, or they may not be aware of
the existence of the HCE consultation
service as a valuable resource. Lack of
awareness that an ethics consultation
is needed could be addressed by informational and educational outreach in
a variety of forums in both the community and in the healthcare facility.
The goal of these efforts should be to
increase understanding about clinical
ethics concerns and raise awareness
about the HCE consultation service
as a resource for addressing these
concerns. HCECs should be mindful
of how they describe and market the
ethics consultation service to avoid the
common misconception that requesting an “ethics consultation” means that
someone has done something “unethical.” In this regard, it may be more
useful and less threatening to describe
an ethics consultation as a way of
protecting a “moral space” for staff to
reflect on complex issues.14
9. Don’t assume that everyone who
wants an ethics consultation will feel
empowered to ask for one. Do take
action to reduce barriers to consultation requests.
Individuals who may be in a position to request an ethics consultation
may not feel empowered to request
one. Lack of empowerment among
healthcare providers to request a
consultation may occur for a variety
of reasons, including a suboptimal
work environment, suboptimal relationships with colleagues, or fear of
retribution for “rocking the boat” or
“whistle-blowing.” Some of these
potential reasons may be related to a
staff member’s location in the organizational hierarchy.15 An unfortunate
consequence of this situation is that
4 Mid-Atlantic Ethics Committee Newsletter

moral distress is often suffered by staff
members who believe that requesting an ethics consultation is the right
thing to do, yet who feel uncomfortable requesting a consultation, either
because the risks are too high or they
are actively prevented from doing
so.16 Lack of empowerment among
patients or family members to request
a consultation may relate to fears of
offending members of the healthcare
team. Strategies for addressing these
barriers include clear institutional
policies and procedures asserting open
access to HCE consultation;17 and
ongoing outreach and education by
HCECs. Education should be directed
toward staff, who may desire an ethics
consultation but who are not able or
willing to request one over and against
resistance by others, and those who
are likely to be resisting a consultation request in the first place. Attention
should be paid to how the service is
described and marketed, as mentioned
in Pearl 8.
10. Don’t confuse legal considerations with HCE consultation. Do
recognize the appropriate roles and
contributions of legal considerations
in HCE consultation.
While legal considerations (including risk management and legal precedent) and ethical concerns related to
a particular case may overlap considerably, they are not synonymous.
This is not surprising, because their
ultimate purposes differ, and the key
stakeholders may be different. For
example, in risk management, one
goal is institutional protection, and the
key stakeholder is typically the institution itself. For HCE consultation, the
ultimate goal is arriving at healthcare
decisions that are ethically optimal and
defensible, and the key stakeholder
(particularly in a case consultation) is
typically a person, such as a patient or
a staff member. Similarly, while legal
considerations (such as case law or
relevant state/federal legislation) may
be very germane and inform ethical
thinking about a case in important
ways, what legal counsel might advise

may differ from what the HCEC might
recommend. Accordingly, the HCEC
must resist the temptation to simply
follow the guidance of legal counsel
or risk managers, and instead arrive
independently at positions and recommendations based on ethical principles
and considerations.
11. Don’t be too sure of yourself. Do
embrace the complexity of each case
with a healthy dose of humility.
Humility in an ethics consultant
is a desirable, if not necessary, trait.
Important features of humility are selfawareness, careful reflection, and a respectful attitude towards others. There
are many reasons to embrace humility:
the absence of a clear, right answer;
the uncertainty often present in clinical
medicine that permeates many cases
for which HCE consultations are
requested; the fact that reasonable
people can and often do disagree about
how to regard the same set of facts;
the reality that consultants’ abilities to
know and understand are limited and
imperfect. In addition, humility may
have the added value of positioning
a consultant to be open to and even
actively seek alternative perspectives,
which may lead to a more complete
process, and ultimately to better consultations. Finally, humility may help
consultants appreciate the boundaries
of their role and serve as a check to
overstepping their authority during a
consultation.18 Humility, therefore, is
the proper disposition of consultants.
12. Don’t do it all on a shoestring.
Do advocate for adequate resources
and support for yourself and your
fellow consultants.
In an era when most of us are accountable to someone for how we
spend our time, and for how our time
is supported, securing adequate resources for the important work we do
is essential. Otherwise, the risk is that
the time we are able to spend on this
work is shortchanged, and the goal of
conducting high quality consultations
is threatened. There are many aspects
of HCECs’ work that could benefit

from financial support. A partial list
includes: continuing education related
to ethics consultation, and to clinical ethics more broadly, for members
of the consultation team; educational
sessions provided by the institution’s HCEC(s) for staff and for the
greater community; compensation for
time spent doing HCE consultations.
HCECs should establish effective
working relationships with institutional administrators to address the issue
of adequate support for their work,
broadly defined.
The full text of this article is available in the Journal of Clinical Ethics, Fall 2012, volume 23, number
3, pages 234-240. For permission
to alter this document in any way,
contact Joseph Carrese at jcarrese@
jhmi.edu).
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FEATURED WEBSITES

In this section, we highlight two websites that may be useful resources for ethics committees.
MARYLAND MOLST
http://marylandmolst.org/

ONCOTALK
http://depts.washington.edu/oncotalk/

The Maryland Medical Orders for Life-Sustaining Therapy
(MOLST) website is dedicated to educating patients and
health care professionals about the MOLST form. It contains information for consumers and health care professionals about the purpose of the form, how to complete it, and
how it should be used to assist in end-of-life care. Readers
can also view a list of future train-the-trainer sessions.

The Oncotalk website is directed toward oncologists and
oncology fellows, but is relevant to anyone who wishes to
improve their knowledge and skills related to communication at the end of life. Oncotalk faculty include Tony Back,
MD, Bob Arnold, MD, Walter Bailey, MD, James Tulsky,
MD and Kelly Fryer-Edwards, MA PhD. The faculty have
prepared the following downloadable learning modules:

The final Maryland MOLST regulations and form became
effective on January 1, 2013. Beginning July 1, 2013,
certain facilities will be mandated to complete the form for
certain patients, including nursing homes, assisted living
facilities, home health agencies, hospices, dialysis centers,
and hospitals.

•

Introduction to Oncotalk Teach

•

Roadmap for a successful teaching encounter

•

Setting useful learning goals

•

Balancing your commitments to patient & fellow

•

Using yourself as a role model

•

Feedback that engages fellows

•

Closing: Take-home messages that resonate

•

Facilitating group learning

•

How learners progress

For each topic, there is a background, "how to do it", pearls
and pitfalls, and a few key references. The “Tough Talk”
section helps clinicians approach difficult conversations
with patients, with a host of tools for both learners and
teachers, including short video clips demonstrating communication techniques.
The Oncotalk website and materials, funded through a
Greenwall Foundation grant, were developed as part of the
Oncotalk training program for Oncology Fellows, which
was funded by the National Cancer Institute.
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CASE PRESENTATION
One of the regular features of this Newsletter is the presentation of a case considered by an ethics committee and an
analysis of the ethical issues involved. Readers are both encouraged to comment on the case or analysis and to submit
other cases that their ethics committee has dealt with. In all cases, identifying information about patients and others in the
case should only be provided with the permission of the patient. Unless otherwise indicated, our policy is not to identify
the submitter or institution. We may also change facts to protect confidentiality. Cases and comments should be sent to
MHECN@law.umaryland.edu, or MHECN, Law & Health Care Program, University of Maryland Francis King Carey
School of Law, 500 W. Baltimore St., Baltimore, MD 21201.
CASE STUDY FROM A MARYLAND HOSPITAL & NURSING
HOME
Mrs. K was 101 years old. She
enjoyed robust health throughout
her life, but experienced progressive
cognitive and functional impairment
over the last 12 years. She lived with
her son’s family. Shortly after her
101st birthday, Mrs. K developed
lung congestion and lethargy and was
taken to an academic teaching hospital. She had no advance directives or
any documented conversation with a
health care provider about her endof-life wishes. The physicians asked
her son what should be done in the
event of a cardiac arrest. Her son took
some offense at the question and said,
“I want you to do everything for my
mother.” As the physicians explained
what cardiac resuscitation meant in
more detail, he became indignant. “So
if a young person has a cardiac arrest,
you try to save her. But with an old
person, you wouldn’t even try? You
would just let her die?! You need to do
everything for my mom. She deserves
the best.”
After two days in the hospital for
treatment of aspiration pneumonia,
Mrs. K became more congested and
developed respiratory failure. Because
of her “full code” status, she was
intubated and placed on mechanical
ventilation. She developed multiple
complications. She was agitated and
received sedation. When the sedation was discontinued, however, she
did not regain consciousness. She did
not respond well to weaning trials, so

a tracheostomy was performed. She
could not eat, so clinicians inserted a
feeding gastrostomy tube. She developed a sacral decubitus ulcer, and
had a Foley catheter in place. On the
27th day of hospitalization, she was
transferred to a nursing facility near
hre son’s home, on the mechanical
ventilator.
The attending physician at the
nursing facility found that Mrs. K
could open her eyes in response to
verbal or tactile stimulation, but she
did not track and did not respond
to visual threat. She did not make
spontaneous purposeful movements.
She withdrew from painful stimuli
and grimaced when suctioned. She did
initiate breaths, but had visible signs
of distress with trials of weaning from
the ventilator. Her large stage 4 sacral
wound was clean and her gastrostomy
tube was functioning well. Her vital
signs were stable. She was transferred
from the hospital as a full code status
patient. Upon nursing home admission, when reviewing the options in
the Medical Orders for Life-sustaining
Treatment (MOLST) form with the
team, her son insisted that “everything
be done” to keep his mother alive. The
nursing facility attending physician
and medical director notified him that
cardio-pulmonary resuscitation (CPR)
would not be attempted in the event of
a cardiac arrest at the facility, because
it would be medically ineffective. The
son was taken aback by this, asking,
“If CPR were medically ineffective, why didn’t they tell me that at
the hospital?” An ethics consult was

requested to discuss the topic of medical ineffectiveness and to consider
what constituted ethically appropriate
treatment options for this 101 year-old
woman.
COMMENTS FROM A PHYSICIAN & NURSING FACILITY
MEDICAL DIRECTOR
As more members of our society
live past 100 years of age, the goals
of medicine in an aging society are
called into question. There are more
centenarians alive today than in any
other time of human history. The
United States leads the world with the
greatest number of centenarians, with
Japan close behind. The 1950 U.S.
census identified 4,440 centenarians in
the United States. The number rose to
10,369 in the 1960 census, 32,194 by
1980 and 53,364 by 2010 (Knach &
Velkoff, 1999; Werner, 2010). Of those
who reach their 100th birthday, about
one in 10 will reach their 105th birthday, and one in 1,000 will reach their
110th birthday. Approximately one in
10,000 persons in the U.S. today are
expected to live to be 100, while only
one in five million are expected to live
to be 110. The longest documented human life span was a woman who lived
122 years and died in 1997. Eighty
percent of centenarians are women.
The burden of disability is very high in
the centenarian population, with about
80% experiencing cognitive impairment, and less than 20% reporting no
significant functional impairment. Half
Cont. on page 8
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of all centenarians in the U.S. live in
nursing facilities (Perls, 2004).
In the absence of advance directives, the most important information
in guiding medical decision making
for the 101 year-old woman in the
case study should have been her health
trajectory prior to her hospitalization.
Regardless of age, a person with a
decade long history of a progressive
dementing illness that has resulted in
functional dependency, incontinence,
dysphagia, and weight loss has entered a period of terminal decline.
The episode of aspiration pneumonia
with respiratory failure is an expected
event in the terminal trajectory of
dementia. The physiologic reserves
in a centenarian are diminished and
are not able to withstand or rebound
from such an event. When the son
asked for “everything” to be done for
his mother, the physician should have
explained to him that all appropriate
and effective interventions would be
performed. Procedures that would
simply prolong the dying process
should not be performed, since they
would not provide benefit to the patient. They would not restore health.
A patient with this person’s history
should not have been intubated and
supported on mechanical ventilation,
because respiratory failure was an
expected part of her terminal illness.
The support of mechanical ventilation
would not be expected to change her
outcome, other than to prolong an inevitable dying process and contribute
to unnecessary suffering on the part of
the patient. It is also not a justifiable
use of health care resources. A decade
ago the question was whether every
person with dementia had to die with
a gastrostomy tube in place. A consensus emerged over the past decade that
demented patients do not benefit from
gastrostomy tubes at the end of their
lives. Therefore their use in demented
patients with a terminal trajectory gen8 Mid-Atlantic Ethics Committee Newsletter

erally is not recommended (Finucane,
Christmas & Travis, 1999). Today the
discussion is whether every end-stage
dementia patient dying of pneumonia
must receive mechanical ventilation
when the family requests that “everything be done.”
The primary care physician had a
duty to this patient and her family to
discuss the typical progression and
outcome of her illness long before
she presented to the hospital with her
acute illness. There were no advance
directives, however, and no history
of any such discussions having taken
place prior to the acute event. In one
study, health care proxies of demented
patients who were presented prognostic data and understood the clinical
complications expected in advanced
dementia were less likely to undergo
burdensome interventions during the
final three months of life. And yet only
18% of the health proxies in the study
stated they had received any prognostic information from a physician
(Mitchell, et al., 2009). Physicians
may not feel capable or confident in
presenting prognostic estimates to patients. Prognostic tools are now available online at www.eprognosis.com to
help physicians estimate prognosis for
elderly patients in various settings and
with various clinical conditions.
Physicians in all settings shy away
from considering and implementing
the concept of medical ineffectiveness.
Perhaps some physicians feel that
talking about death is a form of elder
abuse. Breaking through our deep
cultural denial of death, telling our
patients “memento mori” (“remember
you must die”) may seem to some
as unkind. However, it is a greater
disservice to older adult patients not
to ask about their end-of-life preferences when they are still able to state
their opinions. Older adults generally
have more realistic expectations about

dying than do their adult children.
Physicians may fear being a target for
a lawsuit if they do not do the family’s bidding in the absence of advance
directives. Avoidance of dealing with
hard issues in the name of fear, however, is nothing more than cowardice.
In Atul Gwande’s brave new world
of “Cheesecake Factory Medicine”
(2012), if physicians are simply taking
the family member’s “order,” without
assessing the effectiveness or appropriateness of the intervention, they are
reduced to the role of simply being a
“wait staff.” In some settings it is the
risk managers who may override the
physicians and ethics committee and
tell physicians, “Do whatever the family says and wants,” since the hospital
does not want to face the threat of a
potential law suit from a disgruntled
family member. Within a fee-forservice environment, although there
may be a moral imperative to discuss
prognosis and medical ineffectiveness,
there is a profound financial incentive
not to do so, for both the physician and
the hospital. While medically ineffective treatment and care may be offered
as the path of least resistance with a
family, the arrival of global budgeting
will create a new battleground, as the
provision of ineffective medical interventions may not be considered an acceptable expense. It will be interesting
to watch the dynamics of global budgeting on clinical decision-making at
the bedside. If physicians are rewarded
for “cost effective” practice, there may
be a not-so-subtle conflict when invoking the withholding of interventions
due to medical ineffectiveness. Global
budgeting may further the distrust that
already exists between some family
members and the treating physicians.
Should otherwise healthy, nondemented 101 year-old persons with
pneumonia and respiratory failure
have a trial of intubation and mechanical ventilation? If it could benefit

them, the answer should be yes. But
the change to global budgeting might
deny such a person that opportunity
in the name of medical ineffectiveness based upon advanced age alone.
The physicians in the case presented
should have looked to the pre-hospitalization trajectory of illness to guide
their prognostication and determination of an ethically appropriate plan of
care for this patient.
Medical effectiveness or ineffectiveness of various interventions can depend not only on the specific intervention, but also on the site in which it is
being provided. The term “CPR” has
many different levels of meaning. For
example, if the standard of care in the
nursing facility for CPR is to provide
basic life support [with or without
an automated external defibrillator
(AED)] and call 911, CPR attempts
would be expected to have a much
lower rate of effectiveness than CPR
efforts for a patient in an emergency
department or intensive care unit in
a hospital. In a nursing facility, most
cardiac arrests are unwitnessed. When
CPR is instituted, it is often performed
on patients who have been dead for an
undetermined amount of time. CPR
is most effective when it is performed
immediately in a witnessed arrest, in a
monitored patient with full advanced
cardiac life support capacity readily
available. Patients within intensive
care units may request administration
of medication for cardiac arrhythmia
but no electro-cardioversion. They
may request attempts at cardioversion
without intubation. The new Medical
Orders for Life Sustaining Treatment
(MOLST) form process does not take
these distinctions into account. Although the MOLST is intended to be
valid across sites of care, “code status”
and health care preferences should
be re-evaluated at every transition
of care, to validate the preferences
outlined at the preceding site of care,

and to translate those preferences into
appropriate and site-specific effective
interventions.
The goals of medicine in an aging
society should be to promote health
and to prevent premature mortality
(Callahan, 1987). The question of how
to determine what mortality is premature is often problematic. The Centers
for Disease Control has historically
categorized premature mortality as
that occurring prior to age 65. The
deaths of some people dying even
after the age of 100, however, could be
categorized as premature. The goals of
medicine for centenarians should be to
promote health, to preserve function,
to cure acute illness when possible,
and to relieve suffering. An essential
goal of medicine in an aging society
is to be able to recognize a terminal
trajectory. Once a person has entered
the terminal trajectory, the goal of
medicine should be to relieve suffering
and to refrain from providing burdensome interventions that will only serve
to prolong the dying process.
Rebecca D. Elon, MD, MPH
Associate Professor of Medicine
Johns Hopkins University School of
Medicine
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COMMENTS FROM A NURSE
ETHICS CONSULTANT
The ethical issues at the center of
this case stem from the following
systemic failures in our health care
system:
1. to provide high-quality palliative
end-of-life (EOL) care throughout the disease trajectory.
2. to adequately educate individuals and communicate with them
about end-of-life (EOL) care,
and to document an individual’s
EOL preferences so these are
readily accessible when needed.
3. to define an appropriate medical
standard of care at the end of life
and treat like cases alike across
health care delivery settings.
4. to acknowledge that being a
good steward of limited health
care resources must involve
decisions made by healthcare
providers at the bedside.
When a patient has received excellent palliative care and has participated
in good EOL care planning, it’s less
likely that withholding or withdrawing
interventions against the patient’s or
surrogate’s wishes based on medically
ineffective or non-beneficial treatment
criteria comes up. The latter may create distrust or animosity between the
staff and the patient/surrogate that can
complicate the dying and bereavement
Cont. on page 10
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process, so efforts should be made to
avoid adversarial standoffs. Health
care providers can usually avoid this
by planning ahead to identify when
the main goal of care will shift from
cure to comfort, and by supporting
loved ones along the way. When that
happens, patients/surrogates usually recognize when it’s time to shift
from “doing everything” to keep the
patient alive to “doing everything” to
maximize the quality of the patient’s
remaining time. Minimizing emotional
burden and addressing the psychospiritual hurdles that are often a part
of the dying process for patients and
loved ones is an appropriate goal of
medicine because how individuals
experience the death of someone they
love can have a long-lasting impact on
their future well-being.
The ethics consultant(s) should
explore whether anyone has information about Mrs. K’s wishes, regardless of the absence of documentation
of EOL preferences. It would be the
rare 101 year old who, if she had the
cognitive ability, did not ponder her
own mortality. I recall a conversation
with one centenarian who pointed out
that death became less of a threat the
older she got because “there’s less
life to miss out on.” Yet, centenarians
like Mrs. K may also be cherished
family matriarchs whom others hold
onto dearly as stalwart branches of a
deeply-rooted family tree. They are
survivors who have beat the odds,
and as such, should not be “given up
on.” Yet, family members may also
fall prey to the pitfall of their own
emotions clouding their judgment of
what the patient would want, or what
would be in the patient’s best interests.
They may demand that “everything be
done” to keep the patient alive for the
wrong reasons. Focusing the discussion on what the patient would want
can help family members avoid feeling
like they are being asked to “choose
10 Mid-Atlantic Ethics Committee Newsletter

death” for their loved one.
Unfortunately, acute care medicine
complicates the task of family members sorting through these complex
emotions by failing to draw bright
lines between what can be done and
what should be done medically. Let’s
assume we don’t, and can’t, know
what Mrs. K wants. Although Mrs. K’s
son believes his mother would want to
continue all life-prolonging treatments,
including CPR attempts, without any
evidence of her wishes, the question,
then, is whether doing so is in Mrs.
K’s best interests.
An individual patient’s best interests are determined by calculating the
likelihood of achieving an appropriate
goal from a particular treatment plan
and whether the burden of treatment
is tolerable. “Appropriate goals” are
those that fall within the medical
standard of care. Low-burden interventions that are likely to achieve a
desired goal (e.g., antibiotics to treat
a painful urinary tract infection) may
easily pass the test of acceptability.
High-burden interventions that are
unlikely to achieve a desired goal
(e.g., treatment in an intensive care
unit [ICU] to return an actively dying
patient to pre-ICU functional status)
may readily be deemed unacceptable.
But burden is subjective. For example,
some consider CPR attempts in persons with advanced co-morbidities to
be a high-burden intervention due to
the assault-like nature of chest-compressions and the possibility of breaking ribs, while others consider this to
be a low-burden intervention because
the patient in cardiopulmonary arrest
is unconscious and thus can’t “suffer.”
Burden notwithstanding, many question whether prolonging life, in itself,
is an appropriate goal of medicine,
particularly when a patient has reached
her final days or weeks of life.
Life-prolonging medical interven-

tions are most often limited at the end
of life by acute care triage practices,
such as allocating ICU beds and equipment. But there is considerable variation from one health care facility to the
next in what types of medical technology is offered to patients considered
“terminal.” The challenge is in knowing when a patient is dying and can no
longer benefit from high-tech medical
interventions. Clinicians sometimes
argue that if a patient like Mrs. K can
be “kept alive with machines,” she’s
not “dying.” At the age of 101, with
over a decade of progressive decline
preceding her 100th birthday, and an
inability to breathe or eat on her own,
there should not be such ambiguity
among clinicians as to whether Mrs.
K is dying. This ambiguity confuses
family members. Was Mrs. K’s son
simply asked if he wanted to “keep his
mother alive”? Or was he told that his
mother was dying, and asked how staff
could best support his mom and family
through that process?
We can and should work to avoid
ethical conflicts by better educating individuals about EOL care and
making individuals’ EOL preferences available through accessible
and up-to-date advance directives and
properly-executed MOLST forms. But
this alone won’t solve the problem of
high-burden, low-benefit interventions
at the end of life diverting health care
resources from others who are more
likely to benefit. While a “rational
rationing” plan needs to happen at the
societal level, providers at the bedside
are also obligated to use limited resources wisely, and ethics consultants
should be prepared to assist with these
considerations (Stretch, Hurst & Danis, 2010). As Sheehan (2003) stated,
“Providing expensive medical therapy
with a curative or life-sustaining intent
when a person is incurable and dying is arguably unjust in squandering
resources that are needed elsewhere.”

CRITERIA SUGGESTED BY THE SOCIETY FOR CRITICAL CARE MEDICINE FOR POLICIES TO
LIMIT INADVISABLE TREATMENT
•

Disclosure in the public record

•

Reflection of moral values acceptable to the community

•

Avoidance of an exclusive basis on prognostic scoring systems

•

Provision of appeal mechanisms

•

Recognition by the courts.

•

Recognition by payers that they should formally address criteria for determining when treatments are inadvisable and should share accountability for those decisions.

Consensus statement of the Society of Critical Care Medicine's Ethics Committee regarding futile and other possibly inadvisable treatments (1997). Crit Care Med, 25, 887-891.

How can this be done ethically? In
1991, the American Thoracic Society (ATS) opined that, “[b]ased on
the ethical principles of beneficence
and nonmaleficence, the purpose of a
life-sustaining treatment should be to
restore or maintain a patient’s well being.” In 1997, the ethics committee of
the Society of Critical Care Medicine
(SCCM, 1997) concluded that “[t]reatments should be defined as futile only
when they will not accomplish their
intended goal. Treatments that are
extremely unlikely to be beneficial, are
extremely costly, or are of uncertain
benefit may be considered inappropriate and hence inadvisable, but should
not be labeled futile.” SCCM’s ethics
committee advised using a rationale in
such cases that is “explicit, equitable,
and democratic; that does not disadvantage the disabled, poor, or uninsured; and that recognizes the diversity
of individual values and goals.” (See
box above.)
In Maryland, medical interventions
may be withdrawn or withheld if they
are considered “medically ineffective”
or “ethically inappropriate.” Maryland
law defines medical ineffectiveness as:
“… to a reasonable degree of medical
certainty, a medical procedure will not
prevent or reduce the deterioration of
the health of an individual or prevent
the impending death of an individual.”

Clinicians would have to determine
whether the ventilator or feeding tube
(or dialysis, in the case of kidney shutdown) met this definition for Mrs. K.
CPR attempts would meet the definition, based on Mrs. K's constellation
of co-morbidities, together with her
advanced age.*
Addressing goals of care with excellent palliative care and communication
handles most of the cases. We are far
from achieving this level of excellence
and thus need to improve on this front.
But for those who believe that “prolonging life, regardless of its quality
or treatment burden, is a worthwhile
goal,” we lack a valid rationale for
denying high-burden treatments if we
insist that distributive justice does not
come into play. Our zeal to avoid this
potential conflict of interest further
confounds the issue because we do
not openly discuss the role of resource
stewardship with patients and family
members. As the Affordable Care Act
provides more Americans with health
care coverage, we will be better positioned to address this openly and fairly
(Danis, 2012; Donley & Danis, 2012;
Stretch & Danis, 2012).
So, here we are with Mrs. K and
her son in the nursing home, trying
to figure out the most compassionate
and ethically appropriate way to provide her care, given all the systemic

failures presented. Unless evidence
can be revealed that she would not
want to continue on life support, the
“middle ground” of “no escalation
of treatment” appears to be a valid
compromise, given the complicity of
the medical system in getting her to
this point of dependency on machines
during her dying process. This would
allow for continued ventilator and
feeding tube use until deemed medically ineffective, but no additional
high-burden treatments such as CPR
attempts, dialysis, or ICU transfer.
In cases like these, the nursing home
staff should provide the same comfort
measures as they would for any dying
patient (see box on p. 12).
In short, staff should focus on what
will be done for Mrs. K and her family, rather than what won’t be done.
However, clinicians should make clear
recommendations to the son (including a recommendation to withdraw life
support and focus mainly on comfort
care), rather than offering a “platter
of choices” to the son. The fact that
Mrs. K had many prior encounters
with health care providers, but none
of them documented a conversation
about end-of-life preferences, speaks
to a bigger issue that needs prompt
attention. The ethics consultant(s)
should follow up in some way on this,
Cont. on page 12
Mid-Atlantic Ethics Committee Newsletter 11

Case Presentation
Cont. from page 11

CARE OWED TO DYING PATIENTS
•

Make sure the patient’s symptoms are adequately treated/prevented.

•

Offer the family information about what they are likely to see as their loved one dies.

•

Address any religious traditions that are important to the patient/family.

•

Encourage the family to invite loved ones to say goodbye to the patient.

•

Discuss options for where the patient may spend her final days (e.g., in nursing home with or without hospice support, or transfer to hospice if possible).

Arnold, B. (February, 2011). What to do after the patient is made comfort measures only (CMO) Pallimed case
conferences, 11(2). Available at http://cases.pallimed.org/2011/03/what-to-do-after-patient-is-made.html.

in an effort toward addressing the
systemic failures contributing to cases
like these.
Anita J. Tarzian, PhD, RN
Ethics & Research Consultant;
MHECN Program Coordinator
Associate Professor, University of
Maryland School of Nursing
*If two of Mrs. K’s physicians certified that CPR, or any other medical
intervention, would be medically ineffective or ethically inappropriate, they
could withhold or withdraw it after
informing the daughter of the option
for transfer. If the daughter requested
a transfer, the Health Care Decisions Act requires that life-sustaining
interventions be maintained while
awaiting transfer. However, this need
not include CPR attempts, based on an
interpretation that attempted resuscitation would be ineffective in prolonging Mrs. K’s life.
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FEBRUARY

CALENDAR OF EVENTS

21-22
Empirical Bioethics: Emerging Trends for the 21st Century. Sponsored by the Center for Clinical and Translational Science
and Training. Kingsgate Marriott Conference Hotel, Cincinnati, OH. For more information, contact Bettie Durant at bettie.
durant@cchmc.org, 513.803.2610.
27 (8:30-10AM)
What is Wrong with Markets to Obtain Organs for Transplantation? Public Lecture by Art Caplan, sponsored by the Center
for Bioethics, New York University, New York, NY. Translational Building, 227 East 30th St. (between 2nd and 3rd Ave).
6th Floor, Conference room 619. For more information, visit http://bioethics.as.nyu.edu/page/events.

MARCH

7
Henrietta Lacks Symposium: The Dignity of Difference. Sponsored by the University of Maryland, University of Maryland
SMC Center and University of Maryland School of Nursing, 621 W. Lombard St., Baltimore, MD. For more information,
visit www.umm.edu/hela.
8
Helping Grieving Children and Families. Presenter: Sarah Montgomery, LCSW-C, Coordinator of Children and Family
Programs. Sponsored by Chesapeake Life Center. Baltimore – Living Legacy Foundation, 1730 Twin Springs Road, Suite
200, Baltimore, MD. For more information, visit chesapeakelifecenter.org.
14 (7 PM)
Tenth Annual John Collins Harvey Lecture. Speaker: Daniel Sulmasy, MD, PhD, Kilbride Clinton Professor of Medicine
and Ethics and Associate Director of the MaClean Center for Clinical Medical Ethics at the University of Chicago. Sponsored by Georgetown University’s Center for Bioethics. Salon H of the Leavey Conference Center on the Georgetown
Campus,Washington, DC. For more information, contact Marti Patchell at patchelm@georgetown.edu.
14-16
First Annual Professional Skills Program in Dispute Resolution, sponsored by the Center for Dispute Resolution at the
University of Maryland School of Law (C-DRUM), in partnership with the Straus Institute for Dispute Resolution at Pepperdine University. University of Maryland King Carey School of Law, Baltimore, MD. For more information, visit http://
www.law.umaryland.edu/faculty/conferences/.
14-16
9th International Congress on Clinical Ethics Consultation. Munich, Germany. For more information, visit www.iccec2013.
de.
15
Facts of Illness/Acts of Profession: Edmund Pellegrino and the Ethics of Health Care. Sponsored by Georgetown University Medical Center’s Center for Clinical Bioethics, Salon G of the Leavey Conference Center on the Georgetown
Campus,Washington, DC. For more information, contact Marti Patchell at patchelm@georgetown.edu.
15
Helping Grieving Children and Families. Presenter: Sarah Montgomery, LCSW-C, Coordinator of Children and Family
Programs. Sponsored by Chesapeake Life Center. Baltimore – Grassroots Crisis Intervention, 6700 Freetown Road, Columbia, MD. For more information, visit chesapeakelifecenter.org.
20
Creating Dignified Dialogue: The Role of Health Care Professionals in Ethical Decisions at the End of Life. Presenters:
Shahid Aziz, MD, Medical Director for Adults and Pediatrics at Hospice of the Chesapeake, & Karen Frank, RN MS,
CHTP, Director of Chesapeake Life Center. Sponsored by Chesapeake Life Center, 445 Defense Highway, Annapolis, MD.
For more information, visit chesapeakelifecenter.org.
21-22
Cultivating Ethical Awareness: Moments of Truth. Second Ethics of Caring National Nursing Ethics Conference. Universal
Hilton Hotel, Los Angeles, California. For more information, visit http://ethicsofcaring.org.
21-22
The Politics of Caring: Ethical Issues of Distributive Justice in an Era of Scarce Resources. Sponsored by Emory University’s Center for Ethics and the Health Care Ethics Consortium of Georgia (HCECG). Atlanta, Georgia. For more information, visit www.hcecg.org.
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CALENDAR OF EVENTS (cont'd)
MARCH (cont'd)
22
Digital Ethics: The Impact of Electronic Communications and Social Media on Direct Practice with Clients. 3rd Annual
Judy Levy Ethics Workshop, sponsored by Social Work at Kennedy Krieger Institute, Conference Center at Sheppard
Pratt, 6501 N. Charles St., Towson, MD. For more information, contact Linda Friend at 443-923-2802, friend@kennedykrieger.org.

APRIL

5 (12N-1PM Webinar)
Should Parents Be Allowed to Test Their Children for Adult-Onset Conditions? Debate between geneticist and bioethicist Kelly Ormond and philosopher Rosamond Rhodes. Sponsored by Children’s Mercy Bioethics Center. For more
information and to register, visit http://www.childrensmercy.org/cmbc/.
18
Palliative Care: Healing the Mind, Body and Spirit of Patients and Families Experiencing Serious Illness. Sponsored by
Stella Maris, in the Stella Maris Auditorium, 2300 Dulaney Valley Road, Timonium, MD. For more information, call
410-252-4500, ext. 7208.
18 (4PM)
Palliative Care Seminar Series, Sponsored by the Department of Medical Ethics & Health Policy, University of Pennsylvania, 3401 Market Street, Suite 320, Philadelphia, PA, Joan Karnell Cancer Center (Room TBD). Topic: Pain &
Supportive Care Program Team.
25-26
Clinical Ethics Case Consultation Workshop, sponsored by MedStar Washington Hospital Center. For more information,
contact O. Mary Tawose at Olubukunola.M.Tawose@medstar.net.

MAY

2-3
Intensive Workshop in Healthcare Ethics; Special Topic: “Relating to Cancer.” Sponsored by the Division of Medical
Humanities, College of Medicine, University of Arkansas. For more information, visit http://www.uams.edu/humanities/.
9-10
Bedside, Boardroom, and Boulevard: Health Care Ethics at the Intersections. Sponsored by the Colorado Healthcare
Ethics Forum, Stonebrook Manor Event Center and Gardens in Thornton, Colorado. For more information, visit http://
coloradoethicsforum.org/.
13-14
Intensive Course in Bioethics Consultation Skills, sponsored by the bioethics consultation service at the Montefiore
Medical Center and Albert Einstein College of Medicine, New York, NY. For more information, visit http://www.einstein.yu.edu/masters-in-bioethics.
14 (9A-12:15PM)
Becoming Fully Alive Through Working with the Dying. Sponsored by Stella Maris, in the Stella Maris Auditorium,
2300 Dulaney Valley Road, Timonium, MD. For more information, call 410-252-4500, ext. 7208.
16 (4PM)
Palliative Care Seminar Series, Sponsored by the Department of Medical Ethics & Health Policy, University of Pennsylvania, 3401 Market Street, Suite 320, Philadelphia, PA, CHOP Abramson Building Room 123-AB featuring the CHOP
Pediatric Advanced Care Team (PACT).
16-17
Palliative Care and Ethics Conference. Sponsored by the Center for Healthcare Ethics at Duquesne University, Pittsburgh, PA. For more information, visit http://www.duq.edu/academics/schools/liberal-arts/centers/center-for-healthcareethics.
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22-23
Medical Humanities in Clinical Practice, Medical Humanities Consortium’s Eleventh Annual Meeting. Drew University,
Caspersen School of Graduate Studies, Madison, NJ. For more information, contact Phyllis DeJesse at pdejesse@drew.edu.
28-30
What Does It Mean to Care? Religious Traditions and Health Professions Today. Sponsored by the Program on Medicine
and Religion at the University of Chicago, Westin Hotel, Chicago, IL. For more information, visit https://pmr.uchicago.edu/
events/2013-conference.

JUNE

3-4
Intensive Course in Bioethics Consultation Skills, sponsored by the bioethics consultation service at the Montefiore Medical Center and Albert Einstein College of Medicine, New York, NY. For more information, visit http://www.einstein.yu.edu/
masters-in-bioethics.
3-7
Bioethics: More Relevant Than Ever. Intensive Bioethics Course sponsored by the Kennedy Institute of Ethics, Georgetown, MD. For more information, visit http://kennedyinstitute.georgetown.edu/programs/ibc.cfm.
12-14
Harvard Clinical Bioethics Course, Sponsored by the Harvard Medical School Division of Medical Ethics and Department
of Continuing Education. For more information, visit http://medethics.med.harvard.edu/education/bioethics/.
19-21
Working Together to Shape the Future: 3rd Cambridge Consortium for Bioethics Education, Sponsored by Cambridge University Press. Reid Hall, Paris France. For more information, visit cambridgebioethics.com.
20 (4PM)
Palliative Care Seminar Series, Sponsored by the Department of Medical Ethics & Health Policy, University of Pennsylvania, 3401 Market Street, Suite 320, Philadelphia, PA, PCAM A- CC (conference center) featuring Joshua B. Kayser, MD,
MPH, Assistant Professor of Clinical Medicine, Division of Pulmonary, Allergy and Critical Care.

The Johns Hopkins Berman Institute of Bioethics hosts bioethics seminars on the second and fourth
Monday of each month from 12:15 PM to 1:30 PM. Lunch is provided. To receive emails of seminar
speakers or for more information, contact Tracie Ugamato at tugamato@jhu.edu, 410-614-5550.

The Maryland Healthcare Ethics Committee Network (MHECN) is a membership organization, established by
the Law and Health Care Program at the University of Maryland Francis King Carey School of Law. The purpose
of MHECN is to facilitate and enhance ethical reflection in all aspects of decision making in health care settings
by supporting and providing informational and educational resources to ethics committees serving health care
institutions in the state of Maryland. The Network attempts to achieve this goal by:
• Serving as a resource to ethics committees as they investigate
ethical dilemmas within their institution and as they strive to assist
their institution act consistently with its mission statement;
• Fostering communication and information sharing among Network
members;
• Providing educational programs for ethics committee members, other
healthcare providers, and members of the general public on ethical
issues in health care; and
• Conducting research to improve the functioning of ethics committees
and ultimately the care of patients in Maryland.
MHECN appreciates the support of its individual and institutional members. MHECN also welcomes support from
affiliate members who provide additional financial support.
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